GERD (acid reflux) — all decisions

The Board denied service connection for gastroesophageal reflux disease (GERD) as it was not caused by or aggravated by a service-connected disability.

The Board denied service connection for gastroesophageal reflux disease and irritable bowel syndrome as there is no evidence that these conditions began during active military service or otherwise resulted from active military service.

The Board denied service connection for acid reflux, back pain, bilateral flat feet, left bunion, right bunion and right toe pain, 'black out frequency', right hip pain, bilateral hearing loss, tinnitus, and PTSD as there was no evidence of a current disability or sufficient evidence to support the claim.

The Board granted a 30 percent evaluation for GERD, effective June 30, 2017.

The Board dismissed the Veteran's appeal for service connection for migraines, GERD, left and right upper extremity cubital and carpal tunnel syndrome, and hemorrhoids due to an untimely filing.

The Board has granted the Veteran's request to readjudicate the previously denied claims of entitlement to service connection for right eye and right shoulder. The matters are remanded so the AOJ may consider the claims on their merits.

The Board remands the claims for service connection for gastroesophageal reflux disease (GERD) and a right ankle disability, to include as secondary to a service-connected disability with obesity as an intermediate step, for further development.

The veteran's appeal requests were not timely filed, and good cause was not shown to accept the late filings.

The Board granted a 70 percent rating for PTSD with unspecified depressive disorder, panic disorder, and excoriation disorder with alcohol use disorder but denied other claims including erectile dysfunction, chronic sinusitis, allergic rhinitis, dermatitis, GERD, OSA, CFS, and IBS.

The Board granted service connection for hypertension on a presumptive basis due to exposure to herbicide agents during active duty in Vietnam. The claims for service connection for GERD, right knee disability, left knee disability, low back disability, right shoulder disability, and left shoulder disability were remanded for further development.

The Board granted service connection for right knee patellofemoral pain syndrome, left knee patellofemoral pain syndrome, lumbar spine disorder, and obstructive sleep apnea. The Veteran was also granted a 10 percent rating prior to September 5, 2024, and a 30 percent rating thereafter for GERD.

The Board granted service connection for erectile dysfunction and denied service connection for migraines, GERD, IBS, and hypertension.

The Board denied service connection for gastroesophageal reflux disease (GERD) as it is not etiologically related to the Veteran's active service.

The Board granted service connection for eczema but dismissed the appeal for a compensable evaluation of gastroesophageal reflux disease (GERD) and denied compensable evaluations for shortening of both legs.

The Board denied the veteran's claims for a compensable rating for hypertension, chronic kidney disease stage II, and service connection for right shoulder condition, GERD, and obstructive sleep apnea.

The Board granted a rating of 30 percent for gastroesophageal reflux disease (GERD), resolving all reasonable doubt in favor of the Veteran.

The Board granted service connection for a neck disability, back disability, GERD, hepatitis B, atopic dermatitis, and OSA. Tinnitus was denied.

The Board denied an initial rating in excess of 30 percent prior to May 19, 2024, for IBS with GERD as the Veteran's symptoms did not meet or more nearly approximate the criteria required for a higher rating.

The Board remands the claims for further development, including additional examinations to address the impact of medication on the Veteran's neuropathy and to determine the nature and etiology of his GERD.

The Board remands the claims for service connection for GERD and ulcerative colitis to obtain a new medical opinion that considers the combat presumption and the PACT Act.